U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order. - Amentum Holdings, Inc. AMTM.N: JP Morgan cuts target price to $26 from $31 - Bain Capital Specialty Finance Inc BCSF.N: KBW cuts to market perform from outperform - Bain Capital Specialty Finance Inc BCSF.N: KBW target price to $13 from $15 - Berkshire Hathaway BRKa.N: TD Cowen raises target price to $792,000 from $721,000 - Berkshire Hathaway BRKb.N: TD Cowen raises target price to $529 from $481 - Biomarin Pharmaceutical Inc. BMRN.O: Piper Sandler raises target price to $88 from $82 - CBRE Group, Inc. CBRE.N: Jefferies raises target price to $180 from $170 - Chevron Corporation CVX.N: Jefferies raises target price to $233 from $216 - Chord Energy Corporation CHRD.O: Jefferies raises target price to $133 from $129 - Climb Bio Inc CLYM.O: Baird assumes coverage with outperform rating; target price $21 - Crescent Capital BDC Inc CCAP.O: KBW cuts to market perform from outperform - Crescent Capital BDC Inc CCAP.O: KBW cuts target price to $12 from $13 - Dave Inc. DAVE.O: Piper Sandler initiates coverage with overweight rating; target $390 - Dianthus Therapeutics DNTH.O: Baird assumes coverage with outperform rating; PT $132 - Enliven Therapeutics ELVN.O: Baird assumes coverage with outperform rating; PT $75 - Exxon Mobil XOM.N: Jefferies raises target price to $200 from $184 - Harley-Davidson, Inc. HOG.N: D.A. Davidson raises target price to $33 from $30 - Honeywell Technologies HON.O: Jefferies raises target price to $255 from $240 - Incyte INCY.O: Piper Sandler raises target price to $130 from $110 - Iovance Biotherapeutics Inc IOVA.O: Baird assumes coverage with neutral rating; PT $6 - JLL JLL.N: Jefferies raises target price to $437 from $383 - Lineage, Inc. LINE.O: RBC raises target price to $48 from $44 - Marathon Petroleum Corporation MPC.N: Jefferies raises target price to $413 from $335 - Murphy Oil Corp MUR.N: Jefferies cuts target price to $32 from $38 - Ocular Therapeutix, Inc. OCUL.O: Baird assumes coverage with outperform rating; PT $30 - PayPal PYPL.O: Piper Sandler raises target price to $59 from $42 - Phillips 66 PSX.N: Jefferies raises target price to $242 from $207 - Prudential Financial Inc PRU.N: JP Morgan raises target price to $131 from $129 - Rigel Pharmaceuticals, Inc. RIGL.O: Piper Sandler raises target price to $49 from $40 - Snowflake Inc. SNOW.N: Jefferies raises target price to $385 from $310 - Sofi Technologies, Inc. SOFI.O: Piper Sandler initiates with overweight rating; PT $22 - Spyre Therapeutics Inc SYRE.O: Baird assumes coverage with outperform rating; PT $120 - target Corp TGT.N: D.A. Davidson raises target price to $170 from $155 - Travere Therapeutics, Inc. TVTX.O: Piper Sandler raises target price to $68 from $49 - York Space Systems Inc YSS.N: JP Morgan cuts to neutral from overweight - York Space Systems Inc YSS.N: JP Morgan cuts target price to $17 from $38 Aug. 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Berkshire Hathaway, Exxon Mobil and Honeywell Technologies on Monday. **Highlights** - Berkshire Hathaway BRKa.N: TD Cowen raises target price to $792,000 from $721,000 - Exxon Mobil XOM.N: Jefferies raises target price to $200 from $184 - Honeywell Technologies HON.O: Jefferies raises target price to $255 from $240 - JLL JLL.N: Jefferies raises target price to $437 from $383 - Marathon Petroleum Corporation MPC.N: Jefferies raises target price to $413 from $335

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Research actions on U.S. companies

Wall Street analysts revise targets on Berkshire Hathaway, Exxon Mobil and others

Related News

Best Buy Canada report shows 63% of Canadians buy refurbished, open-box or trade-in tech in past year

Technicals-CBOT corn may rise to $4.87

China's recovery sputters as consumption, output lose steam

Prudential Financial Inc <PRU.N>: JPMorgan raises target price to $131 from $129

Genco Shipping & Trading Projects Q3 and Q4 Dividends of Over $2 Per Share